Cargando…
The effect of transarterial chemoembolization therapy on survival in patients with non-resectable hepatocellular carcinoma: Single-center study results
BACKGROUND AND AIM: This study was designed to investigate the tumor response and effect of drug-eluting transarterial chemoembolization (DEB-TACE) treatment on survival in patients diagnosed with hepatocellular carcinoma (HCC). MATERIALS AND METHODS: The records of 40 patients who underwent DEB-TAC...
Autores principales: | Kolu, Mehmet, Dere, Osman, Sonmez, Suleyman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138947/ https://www.ncbi.nlm.nih.gov/pubmed/35784908 http://dx.doi.org/10.14744/hf.2021.2021.0029 |
Ejemplares similares
-
Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Zhao, Dongxu, et al.
Publicado: (2023) -
Prevention of hepatocellular carcinoma and monitoring of high-risk patients
por: Kaya, Eda, et al.
Publicado: (2022) -
The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection
por: Na, Seong Kyun, et al.
Publicado: (2018) -
Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience
por: Bettinger, Dominik, et al.
Publicado: (2017) -
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)